The human body experiences various health problems because of inflammation, which can lead to joint pain, heart disease and ...

Genfleet Therapeutics (Shanghai), Inc. Class H ( ($HK:2595) ) just unveiled an announcement. GenFleet Therapeutics has initiated the first ...

Pasithea Therapeutics Corp ( ($KTTA) ) has shared an update. On November 28, 2025, Pasithea Therapeutics Corp announced a public offering of ...

Erasca, Inc. (NASDAQ:ERAS) is one of the 12 hot penny stocks to invest in right now. On November 14, 2025, Erasca, Inc.

Plexiform neurofibromas (PNF) are benign, often infiltrative tumours of the peripheral nerve sheath classically linked to ...

Extends cash runway through at least the first half of 2028Led by Vivo Capital, Janus Henderson Investors, Coastlands Capital, Columbia ...

Extends cash runway through at least the first half of 2028Led by healthcare-dedicated investors, including Vivo Capital, Janus Henderson ...

By Dr. Priyom Bose, Ph.D. Study: From obesity to cancer: Gut microbiome mechanisms, biomarkers, and U.S. public health ...

Summary • Erasca, Inc. (ERAS) shares rose 14.1% to $3.30 amid conference participation.• The company is attending the Evercore Healthcare Conference to discuss RAS/MAPK therapy advancements.• Analysts ...

Early data suggest retatrutide may drive faster and greater weight loss, which fuels interest in looksmaxxing spaces.

Dr. Saurabh Sethi, a gastroenterologist trained at AIIMS, Harvard, and Stanford universities, recently shared a video on ...

Novo Nordisk says it still thinks GLP-1 drugs could be a promising treatment for Alzheimer’s, despite two disappointing ...